Body fat composition as predictive factor for treatment response in patients with newly diagnosed multiple myeloma – subgroup analysis of the prospective GMMG MM5 trial

por GroΔ, Jonathan P., Nattenmüller, Johanna, Hemmer, Stefan, Tichy, Diana, Krzykalla, Julia, Goldschmidt, Hartmut, Bertsch, Uta, Delorme, Stefan, Kauczor, Hans-Ulrich, Hillengass, Jens, Merz, Maximilian
Publicado 2017

Pre-transplant testosterone and outcome of men after allogeneic stem cell transplantation

por Radujkovic, Aleksandar, Kordelas, Lambros, Krzykalla, Julia, Benner, Axel, Schult, David, Majer-Lauterbach, Joshua, Beelen, Dietrich W., Müller-Tidow, Carsten, Kasperk, Christian, Dreger, Peter, Luft, Thomas
Publicado 2020

EASIX and Severe Endothelial Complications After CD19-Directed CAR-T Cell Therapy—A Cohort Study

por Korell, Felix, Penack, Olaf, Mattie, Mike, Schreck, Nicholas, Benner, Axel, Krzykalla, Julia, Wang, Zixing, Schmitt, Michael, Bullinger, Lars, Müller-Tidow, Carsten, Dreger, Peter, Luft, Thomas
Publicado 2022

Integrative prognostic models predict long-term survival after immunochemotherapy in chronic lymphocytic leukemia patients

por Bloehdorn, Johannes, Krzykalla, Julia, Holzmann, Karlheinz, Gerhardinger, Andreas, Jebaraj, Billy Michael Chelliah, Bahlo, Jasmin, Humphrey, Kathryn, Tausch, Eugen, Robrecht, Sandra, Mertens, Daniel, Schneider, Christof, Fischer, Kirsten, Hallek, Michael, Döhner, Hartmut, Benner, Axel, Stilgenbauer, Stephan
Publicado 2021

P417: GENOMIC LANDSCAPE AND PROGNOSIS IN OLDER ACUTE MYELOID LEUKEMIA PATIENTS NOT ELIGIBLE FOR INTENSIVE CHEMOTHERAPY

por Jahn, Ekaterina, Saadati, Maral, Fenaux, Pierre, Gobbi, Marco, Roboz, Gail, Bullinger, Lars, Lutsik, Pavlo, Riedel, Anna, Plass, Christoph, Jahn, Nikolaus, Walter, Claudia, Holzmann, Karlheinz, Hao, Yong, Naim, Sue, Schreck, Nicholas, Krzykalla, Julia, Benner, Axel, Keer, Harold, Azab, Mohammad, Döhner, Konstanze, Döhner, Hartmut
Publicado 2023

Cluster of differentiation 33 single nucleotide polymorphism rs12459419 is a predictive factor in patients with nucleophosmin1-mutated acute myeloid leukemia receiving gemtuzumab o...

por Teich, Katrin, Krzykalla, Julia, Kapp-Schwoerer, Silke, Gaidzik, Verena I., Schlenk, Richard F., Paschka, Peter, Weber, Daniela, Fiedler, Walter, Kühn, Michael W. M., Schroeder, Thomas, Mayer, Karin, Lübbert, Michael, Ramachandran, Dhanya, Benner, Axel, Ganser, Arnold, Döhner, Hartmut, Heuser, Michael, Döhner, Konstanze, Thol, Felicitas
Publicado 2021

Clinical impact of the genomic landscape and leukemogenic trajectories in non-intensively treated elderly acute myeloid leukemia patients

por Jahn, Ekaterina, Saadati, Maral, Fenaux, Pierre, Gobbi, Marco, Roboz, Gail J., Bullinger, Lars, Lutsik, Pavlo, Riedel, Anna, Plass, Christoph, Jahn, Nikolaus, Walter, Claudia, Holzmann, Karlheinz, Hao, Yong, Naim, Sue, Schreck, Nicholas, Krzykalla, Julia, Benner, Axel, Keer, Harold N., Azab, Mohammad, Döhner, Konstanze, Döhner, Hartmut
Publicado 2023

Correction: Clinical impact of the genomic landscape and leukemogenic trajectories in non-intensively treated elderly acute myeloid leukemia patients

por Jahn, Ekaterina, Saadati, Maral, Fenaux, Pierre, Gobbi, Marco, Roboz, Gail J., Bullinger, Lars, Lutsik, Pavlo, Riedel, Anna, Plass, Christoph, Jahn, Nikolaus, Walter, Claudia, Holzmann, Karlheinz, Hao, Yong, Naim, Sue, Schreck, Nicholas, Krzykalla, Julia, Benner, Axel, Keer, Harold N., Azab, Mohammad, Döhner, Konstanze, Döhner, Hartmut
Publicado 2023

Genomic landscape of patients with FLT3-mutated acute myeloid leukemia (AML) treated within the CALGB 10603/RATIFY trial

por Jahn, Nikolaus, Jahn, Ekaterina, Saadati, Maral, Bullinger, Lars, Larson, Richard A., Ottone, Tiziana, Amadori, Sergio, Prior, Thomas W., Brandwein, Joseph M., Appelbaum, Frederick R., Medeiros, Bruno C., Tallman, Martin S., Ehninger, Gerhard, Heuser, Michael, Ganser, Arnold, Pallaud, Celine, Gathmann, Insa, Krzykalla, Julia, Benner, Axel, Bloomfield, Clara D., Thiede, Christian, Stone, Richard M., Döhner, Hartmut, Döhner, Konstanze
Publicado 2022

Gemtuzumab Ozogamicin in NPM1-Mutated Acute Myeloid Leukemia: Early Results From the Prospective Randomized AMLSG 09-09 Phase III Study

por Schlenk, Richard F., Paschka, Peter, Krzykalla, Julia, Weber, Daniela, Kapp-Schwoerer, Silke, Gaidzik, Verena I., Leis, Claudia, Fiedler, Walter, Kindler, Thomas, Schroeder, Thomas, Mayer, Karin, Lübbert, Michael, Wattad, Mohammed, Götze, Katharina, Horst, Heinz A., Koller, Elisabeth, Wulf, Gerald, Schleicher, Jan, Bentz, Martin, Greil, Richard, Hertenstein, Bernd, Krauter, Jürgen, Martens, Uwe, Nachbaur, David, Abu Samra, Maisun, Girschikofsky, Michael, Basara, Nadezda, Benner, Axel, Thol, Felicitas, Heuser, Michael, Ganser, Arnold, Döhner, Konstanze, Döhner, Hartmut
Publicado 2020

The shared frameshift mutation landscape of microsatellite-unstable cancers suggests immunoediting during tumor evolution

por Ballhausen, Alexej, Przybilla, Moritz Jakob, Jendrusch, Michael, Haupt, Saskia, Pfaffendorf, Elisabeth, Seidler, Florian, Witt, Johannes, Hernandez Sanchez, Alejandro, Urban, Katharina, Draxlbauer, Markus, Krausert, Sonja, Ahadova, Aysel, Kalteis, Martin Simon, Pfuderer, Pauline L., Heid, Daniel, Stichel, Damian, Gebert, Johannes, Bonsack, Maria, Schott, Sarah, Bläker, Hendrik, Seppälä, Toni, Mecklin, Jukka-Pekka, Ten Broeke, Sanne, Nielsen, Maartje, Heuveline, Vincent, Krzykalla, Julia, Benner, Axel, Riemer, Angelika Beate, von Knebel Doeberitz, Magnus, Kloor, Matthias
Publicado 2020

Midostaurin plus intensive chemotherapy for younger and older patients with AML and FLT3 internal tandem duplications

por Döhner, Hartmut, Weber, Daniela, Krzykalla, Julia, Fiedler, Walter, Wulf, Gerald, Salih, Helmut, Lübbert, Michael, Kühn, Michael W. M., Schroeder, Thomas, Salwender, Hans, Götze, Katharina, Westermann, Jörg, Fransecky, Lars, Mayer, Karin, Hertenstein, Bernd, Ringhoffer, Mark, Tischler, Hans-Joachim, Machherndl-Spandl, Sigrid, Schrade, Anika, Paschka, Peter, Gaidzik, Verena I., Theis, Frauke, Thol, Felicitas, Heuser, Michael, Schlenk, Richard F., Bullinger, Lars, Saadati, Maral, Benner, Axel, Larson, Richard, Stone, Richard, Döhner, Konstanze, Ganser, Arnold
Publicado 2022

Molecular landscape and prognostic impact of FLT3-ITD insertion site in acute myeloid leukemia: RATIFY study results

por Rücker, Frank G., Du, Ling, Luck, Tamara J., Benner, Axel, Krzykalla, Julia, Gathmann, Insa, Voso, Maria Teresa, Amadori, Sergio, Prior, Thomas W., Brandwein, Joseph M., Appelbaum, Frederick R., Medeiros, Bruno C., Tallman, Martin S., Savoie, Lynn, Sierra, Jorge, Pallaud, Celine, Sanz, Miguel A., Jansen, Joop H., Niederwieser, Dietger, Fischer, Thomas, Ehninger, Gerhard, Heuser, Michael, Ganser, Arnold, Bullinger, Lars, Larson, Richard A., Bloomfield, Clara D., Stone, Richard M., Döhner, Hartmut, Thiede, Christian, Döhner, Konstanze
Publicado 2021

Multi-platform profiling characterizes molecular subgroups and resistance networks in chronic lymphocytic leukemia

por Bloehdorn, Johannes, Braun, Andrejs, Taylor-Weiner, Amaro, Jebaraj, Billy Michael Chelliah, Robrecht, Sandra, Krzykalla, Julia, Pan, Heng, Giza, Adam, Akylzhanova, Gulnara, Holzmann, Karlheinz, Scheffold, Annika, Johnston, Harvey E., Yeh, Ru-Fang, Klymenko, Tetyana, Tausch, Eugen, Eichhorst, Barbara, Bullinger, Lars, Fischer, Kirsten, Weisser, Martin, Robak, Tadeusz, Schneider, Christof, Gribben, John, Dahal, Lekh N., Carter, Mathew J., Elemento, Olivier, Landau, Dan A., Neuberg, Donna S., Cragg, Mark S., Benner, Axel, Hallek, Michael, Wu, Catherine J., Döhner, Hartmut, Stilgenbauer, Stephan, Mertens, Daniel
Publicado 2021